Suggested improvements to the overt aggression scale-modified

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 1, 2010, Pages

  Mattes, Jeffrey A ^a  

^a Psychopharmacology Research Association of Princeton   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; OXCARBAZEPINE;

AGGRESSION; HUMAN; INTERRATER RELIABILITY; LETTER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERT AGGRESSION SCALE MODIFIED; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 76749155822     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.22.1.123.e1     Document Type: Letter

References (5)

1. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al: Development of neuropharmacologically based behavior assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neuroscience 1991; 3:544-551
2. Yudofsky SC, Silver JM, Jackson W, et al: The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 143: 35-39
3. Hollander E, Tracy KA, Swann AC, et al: Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 2003; 28:1186-1197
4. Mattes JA: Oxcarbazepine in patients with impulsive aggression: a doubleblind, placebo controlled trial. J Clin Psychopharmacology 2005; 25:575-579
5. Mattes JA: Levetiracetam in patients with impulsive aggression: a double-blind, placebo controlled trial. J Clin Psychiatry 2008; 69:310-315